0.70
Envoy Medical Inc stock is traded at $0.70, with a volume of 166.59K.
It is up +2.15% in the last 24 hours and up +21.70% over the past month.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
See More
Previous Close:
$0.6853
Open:
$0.6701
24h Volume:
166.59K
Relative Volume:
0.25
Market Cap:
$53.82M
Revenue:
$222.00K
Net Income/Loss:
$-22.92M
P/E Ratio:
-0.4861
EPS:
-1.44
Net Cash Flow:
$-15.47M
1W Performance:
-2.45%
1M Performance:
+21.70%
6M Performance:
-48.15%
1Y Performance:
-46.56%
Envoy Medical Inc Stock (COCH) Company Profile
Name
Envoy Medical Inc
Sector
Industry
Phone
651-361-8000
Address
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
COCH
Envoy Medical Inc
|
0.70 | 52.69M | 222.00K | -22.92M | -15.47M | -1.44 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-24 | Initiated | Ascendiant Capital Markets | Buy |
Envoy Medical Inc Stock (COCH) Latest News
COCH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
COCH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Envoy Medical Regains Nasdaq Listing Compliance After Financing - TipRanks
Envoy Medical (NASDAQ: COCH) regains compliance with Nasdaq listing rule - Stock Titan
Revenue Check: Can Envoy Medical Inc Equity Warrant be the next market leaderQuarterly Performance Summary & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Envoy Medical secures three new patents, bolstering cochlear implant leadership - Indian Pharma Post
Envoy Medical Nears Enrollment Completion for Acclaim Cochlear Implant Trial - The Hearing Review
Envoy Medical regains Nasdaq compliance after balance sheet work - Investing.com Australia
Envoy Medical (COCH) Price Target Increased by 15.15% to 9.69 - Nasdaq
Envoy Medical regains Nasdaq compliance after balance sheet work By Investing.com - Investing.com South Africa
COCHW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Envoy Medical Regains Compliance with Nasdaq Listing Requirement - TMX Newsfile
Nasdaq clears Envoy Medical after $35M value shortfall - Stock Titan
Envoy Medical receives three new patents for cochlear implant tech By Investing.com - Investing.com India
Envoy Medical receives three new patents for cochlear implant tech - Investing.com Australia
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space - marketscreener.com
Three new patents detail Envoy’s fully implanted cochlear tech - Stock Titan
Does Envoy Medical Inc. stock benefit from AI growthTrade Analysis Summary & High Win Rate Trade Alerts - mfd.ru
What are analysts’ price targets for Envoy Medical Inc.July 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial - The Globe and Mail
Envoy Medical raises $30 million, nears completion of cochlear implant trial By Investing.com - Investing.com South Africa
Analyzing Envoy Medical (NASDAQ:COCH) and TearLab (OTCMKTS:TEAR) - Defense World
Envoy Medical raises $30 million, nears completion of cochlear implant trial - Investing.com Nigeria
Fully implanted cochlear implant nears trial end as Envoy's $30M financing lands - Stock Titan
Glen Taylor Buys 241% More Envoy Medical Shares - simplywall.st
Envoy Medical interim CFO buys $85k in shares - Investing.com South Africa
Envoy Medical interim CFO buys $85k in shares By Investing.com - Investing.com Canada
Glen Taylor buys $7.5m in Envoy Medical (COCH) stock - Investing.com
Glen Taylor buys $7.5m in Envoy Medical (COCH) stock By Investing.com - Investing.com Australia
Envoy Medical (COCH) investor details 84.8% beneficial ownership stake - Stock Titan
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - marketscreener.com
Form 4: Lucas Brent T. reports purchase transactions in COCH - Stock Titan
Can Envoy Medical Inc. Equity Warrant continue delivering strong returnsMarket Growth Report & Capital Protection Trade Alerts - mfd.ru
Envoy Medical shares skyrocket after FDA clears final stage of pivotal Acclaim® cochlear implant trial - MSN
Envoy Medical Closes Upsized Public Offering to Fund Growth - TipRanks
Envoy Medical Signs Multiple Financing Agreements - TradingView
Is Envoy Medical Inc. Equity Warrant stock gaining market share2025 Dividend Review & Daily Profit Maximizing Tips - mfd.ru
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering - TradingView
Is Envoy Medical Inc. stock risky to hold now2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Envoy Medical Grants Stock Options to Key Executives - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering - TMX Newsfile
Envoy Medical announces pricing of up to $78M public offering - MSN
Envoy Medical (NASDAQ: COCH) gets 7.87% stake filing from Ayrton - Stock Titan
Hearing implant maker Envoy Medical raises $30M, eyes FDA-tied warrant cash - Stock Titan
Is Envoy Medical Inc. stock a dividend growth opportunityGap Down & Daily Growth Stock Tips - mfd.ru
Why Envoy Medical Inc. stock remains on buy lists2025 Support & Resistance & Daily Stock Trend Reports - mfd.ru
Envoy Medical Inc Stock (COCH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Envoy Medical Inc Stock (COCH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Potashnick Robert | Interim CFO |
Feb 12 '26 |
Buy |
0.40 |
212,500 |
85,000 |
212,500 |
| Kantor Susan | Director |
Feb 12 '26 |
Buy |
0.40 |
96,150 |
38,460 |
174,037 |
| BRYNELSEN CHARLES | Director |
Feb 12 '26 |
Buy |
0.40 |
1,000,000 |
400,000 |
1,050,000 |
| Lucas Brent T. | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.40 |
62,500 |
25,000 |
297,090 |
| TAYLOR GLEN A | 10% Owner |
Feb 12 '26 |
Buy |
0.40 |
18,750,000 |
7,500,000 |
21,703,607 |
| Patel Mona Chetan | Director |
Jun 11 '25 |
Buy |
1.47 |
2,500 |
3,675 |
20,000 |
| Patel Mona Chetan | Director |
Jun 06 '25 |
Buy |
1.46 |
10,000 |
14,600 |
17,500 |
| BRYNELSEN CHARLES | Director |
May 27 '25 |
Buy |
1.65 |
35,000 |
57,673 |
50,000 |
| BRYNELSEN CHARLES | Director |
May 23 '25 |
Buy |
1.64 |
13,000 |
21,363 |
15,000 |
| BRYNELSEN CHARLES | Director |
May 22 '25 |
Buy |
1.68 |
2,000 |
3,367 |
2,000 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):